Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 3/2023

21-03-2022 | Metastasis | Original Article – Clinical Oncology

Characteristics and survival of primary vaginal malignancy: an analysis of the German nationwide cancer registry data

Author: Dirk Michael Forner

Published in: Journal of Cancer Research and Clinical Oncology | Issue 3/2023

Login to get access

Abstract

Background

Vaginal neoplasms are rare. To study the survival of patients depending on tumour characteristics and age, the data from the national cancer registries in Germany were analysed.

Methods

In a retrospective analysis, data from 2006 to 2015 on disease stage, survival, and factors that might affect prognosis were analysed.

Results

Altogether, out of 4004 datasets, 2194 were deemed adequate to be included in the analysis. Overall survival at 5 years (5YSR) and relative survival (5RSR) were 48.6% (95%CI 45.4–52.1%) and 58.7% (95%CI 55.3–61.2%) for carcinomas, but significantly worse at 20.2% (95%CI 8.3–32.0%) and 24.2% (95%CI 16.4–32.0%) for melanomas and 38.3% (95%CI 23.3–53.5%) and 44.4% (95%CI 31.5–56.8%) for sarcomas. 5YSR and 5RSR correlated significantly with FIGO stages (5YSR: 66.9–10.1%; 5RSR: 81.7–11.9%, = 0.04). Furthermore, survival depended on the absence of LN metastases (5RSR: 59.1% vs. 38.0%, < 0.001), and the tumour grading had an influence (5RSR: 83.7–52.1%). We also noted that prognosis was worse for older patients ≥75 years (5RSR:51.2%) than for patients <55 years (62.2%) and 55–74 years of age (61.6%).

Conclusion

Unless LN metastases, local advanced tumours and G3 grading are associated with a worse prognosis. Relative survival of older patients decreases, perhaps indicating that treatment compromises have been made
Footnotes
1
Robert Koch-Institute, Department of Epidemiology and Health Monitoring, German Centre for Cancer Registry Data, Berlin, Germany.
 
Literature
go back to reference Alemany L, Saunier M, Tinoco L et al (2014) Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples. Eur J Cancer 50:2846–2854CrossRefPubMed Alemany L, Saunier M, Tinoco L et al (2014) Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples. Eur J Cancer 50:2846–2854CrossRefPubMed
go back to reference American Joint Committee on Cancer. Vagina. In: AJCC Cancer Staging Manual, 8th ed. New York, NY: Springer; 2017:641–47. American Joint Committee on Cancer. Vagina. In: AJCC Cancer Staging Manual, 8th ed. New York, NY: Springer; 2017:641–47.
go back to reference Bertoli HK, Baandrup L, Aalborg GL, Kjaer AK, Thomsen LT, Kjaer SK (2020) Time trends in the incidence and survival of vaginal squamous cell carcinoma and high-grade vaginal intraepithelial neoplasia in Denmark - a nationwide population-based study. Gynecol Oncol 158:734–739CrossRefPubMed Bertoli HK, Baandrup L, Aalborg GL, Kjaer AK, Thomsen LT, Kjaer SK (2020) Time trends in the incidence and survival of vaginal squamous cell carcinoma and high-grade vaginal intraepithelial neoplasia in Denmark - a nationwide population-based study. Gynecol Oncol 158:734–739CrossRefPubMed
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424 (Erratum in: CA Cancer J Clin. 2020;70:313.)CrossRefPubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424 (Erratum in: CA Cancer J Clin. 2020;70:313.)CrossRefPubMed
go back to reference Cao D, Wu D, Xu Y (2021) Vaginal intraepithelial neoplasia in patients after total hysterectomy. Curr Probl Cancer. 45:100687CrossRefPubMed Cao D, Wu D, Xu Y (2021) Vaginal intraepithelial neoplasia in patients after total hysterectomy. Curr Probl Cancer. 45:100687CrossRefPubMed
go back to reference Chyle V, Zagars GK, Wheeler JA, Wharton JT, Delclos L (1996) Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int J Radiat Oncol Biol Phys 35:891–905CrossRefPubMed Chyle V, Zagars GK, Wheeler JA, Wharton JT, Delclos L (1996) Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int J Radiat Oncol Biol Phys 35:891–905CrossRefPubMed
go back to reference Daling JR, Madeleine MM, Schwartz SM et al (2002) A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84:263–270CrossRefPubMed Daling JR, Madeleine MM, Schwartz SM et al (2002) A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84:263–270CrossRefPubMed
go back to reference Di Donato V, Bellati F, Fischetti M, Plotti F, Perniola G, Panici PB (2012) Vaginal cancer. Crit Rev Oncol Hematol 81:286–295CrossRefPubMed Di Donato V, Bellati F, Fischetti M, Plotti F, Perniola G, Panici PB (2012) Vaginal cancer. Crit Rev Oncol Hematol 81:286–295CrossRefPubMed
go back to reference Ebisch RMF, Rutten DWE, IntHout J et al (2017) Long-lasting increased risk of human papillomavirus-related carcinomas and premalignancies after cervical intraepithelial neoplasia grade 3: a population-based cohort study. J Clin Oncol 35:2542–2550CrossRefPubMed Ebisch RMF, Rutten DWE, IntHout J et al (2017) Long-lasting increased risk of human papillomavirus-related carcinomas and premalignancies after cervical intraepithelial neoplasia grade 3: a population-based cohort study. J Clin Oncol 35:2542–2550CrossRefPubMed
go back to reference Ederer F, Astell LM, Cutler SJ (1961) The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6:101–121PubMed Ederer F, Astell LM, Cutler SJ (1961) The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6:101–121PubMed
go back to reference Gunderson CC, Nugent EK, Yunker AC et al (2013) Vaginal cancer: the experience from 2 large academic centers during a 15-year period. J Low Genit Tract Dis. 17:409–13CrossRefPubMed Gunderson CC, Nugent EK, Yunker AC et al (2013) Vaginal cancer: the experience from 2 large academic centers during a 15-year period. J Low Genit Tract Dis. 17:409–13CrossRefPubMed
go back to reference Jentschke M, Hoffmeister V, Soergel P, Hillemanns P (2016) Clinical presentation, treatment and outcome of vaginal intraepithelial neoplasia. Arch Gynecol Obstet 293:415–419CrossRefPubMed Jentschke M, Hoffmeister V, Soergel P, Hillemanns P (2016) Clinical presentation, treatment and outcome of vaginal intraepithelial neoplasia. Arch Gynecol Obstet 293:415–419CrossRefPubMed
go back to reference Kucera H, Vavra N (1991) Radiation management of primary carcinoma of the vagina: clinical and histopathological variables associated with survival. Gynecol Oncol 40:12–16CrossRefPubMed Kucera H, Vavra N (1991) Radiation management of primary carcinoma of the vagina: clinical and histopathological variables associated with survival. Gynecol Oncol 40:12–16CrossRefPubMed
go back to reference Merino MJ (1991) Vaginal cancer: the role of infectious and environmental factors. Am J Obstet Gynecol 165:1255–1262CrossRefPubMed Merino MJ (1991) Vaginal cancer: the role of infectious and environmental factors. Am J Obstet Gynecol 165:1255–1262CrossRefPubMed
go back to reference Perez CA, Camel HM, Galakatos AE et al (1988) Definitive irradiation in carcinoma of the vagina: long-term evaluation and results. Int J Radiat Oncol Biol Phys 15:1283–1290CrossRefPubMed Perez CA, Camel HM, Galakatos AE et al (1988) Definitive irradiation in carcinoma of the vagina: long-term evaluation and results. Int J Radiat Oncol Biol Phys 15:1283–1290CrossRefPubMed
go back to reference Perez CA, Grigsby PW, Garipagaoglu M et al (1999) Factors affecting longterm outcome of irradiation in carcinoma of the vagina. Int J Radiat Oncol Biol Phys 44:37–45CrossRefPubMed Perez CA, Grigsby PW, Garipagaoglu M et al (1999) Factors affecting longterm outcome of irradiation in carcinoma of the vagina. Int J Radiat Oncol Biol Phys 44:37–45CrossRefPubMed
go back to reference Puri S, Asotra S (2019) Primary vaginal malignant melanoma: a rare entity with review of literature. J Cancer Res Ther 15:1392–1394CrossRefPubMed Puri S, Asotra S (2019) Primary vaginal malignant melanoma: a rare entity with review of literature. J Cancer Res Ther 15:1392–1394CrossRefPubMed
go back to reference Reshko LB, Gaskins JT, Metzinger DS, Todd SL, Eldredge-Hindy HB, Silva SR (2021) The impact of brachytherapy boost and radiotherapy treatment duration on survival in patients with vaginal cancer treated with definitive chemoradiation. Brachytherapy 20:75–84CrossRefPubMed Reshko LB, Gaskins JT, Metzinger DS, Todd SL, Eldredge-Hindy HB, Silva SR (2021) The impact of brachytherapy boost and radiotherapy treatment duration on survival in patients with vaginal cancer treated with definitive chemoradiation. Brachytherapy 20:75–84CrossRefPubMed
go back to reference Sopracordevole F, Barbero M, Clemente N et al (2016) High-grade vaginal intraepithelial neoplasia and risk of progression to vaginal cancer: a multicentre study of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV). Eur Rev Med Pharmacol Sci 20:818–824PubMed Sopracordevole F, Barbero M, Clemente N et al (2016) High-grade vaginal intraepithelial neoplasia and risk of progression to vaginal cancer: a multicentre study of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV). Eur Rev Med Pharmacol Sci 20:818–824PubMed
go back to reference Tainio K, Jakobsson M, Louvanto K et al (2016) Randomised trial on treatment of vaginal intraepithelial neoplasia-Imiquimod, laser vaporisation and expectant management. Int J Cancer 139:2353–2358CrossRefPubMed Tainio K, Jakobsson M, Louvanto K et al (2016) Randomised trial on treatment of vaginal intraepithelial neoplasia-Imiquimod, laser vaporisation and expectant management. Int J Cancer 139:2353–2358CrossRefPubMed
go back to reference Urbański K, Kojs Z, Reinfuss M, Fabisiak W (1996) Primary invasive vaginal carcinoma treated with radiotherapy: analysis of prognostic factors. Gynecol Oncol 60:16–21CrossRefPubMed Urbański K, Kojs Z, Reinfuss M, Fabisiak W (1996) Primary invasive vaginal carcinoma treated with radiotherapy: analysis of prognostic factors. Gynecol Oncol 60:16–21CrossRefPubMed
go back to reference Wu X, Matanoski G, Chen VW, Saraiya M, Coughlin SS, King JB, Tao XG et al (2008) Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer 113:2873–82CrossRefPubMed Wu X, Matanoski G, Chen VW, Saraiya M, Coughlin SS, King JB, Tao XG et al (2008) Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer 113:2873–82CrossRefPubMed
go back to reference Yagi A, Ueda Y, Kakuda M et al (2017) Descriptive epidemiological study of vaginal cancer using data from the Osaka Japan population-based cancer registry: Long-term analysis from a clinical viewpoint. Medicine 96:e7751CrossRefPubMedPubMedCentral Yagi A, Ueda Y, Kakuda M et al (2017) Descriptive epidemiological study of vaginal cancer using data from the Osaka Japan population-based cancer registry: Long-term analysis from a clinical viewpoint. Medicine 96:e7751CrossRefPubMedPubMedCentral
go back to reference Yang J, Delara R, Magrina J et al (2020) Management and outcomes of primary vaginal cancer. Gynecol Oncol 159:456–463CrossRefPubMed Yang J, Delara R, Magrina J et al (2020) Management and outcomes of primary vaginal cancer. Gynecol Oncol 159:456–463CrossRefPubMed
Metadata
Title
Characteristics and survival of primary vaginal malignancy: an analysis of the German nationwide cancer registry data
Author
Dirk Michael Forner
Publication date
21-03-2022
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 3/2023
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-022-03982-7

Other articles of this Issue 3/2023

Journal of Cancer Research and Clinical Oncology 3/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare